ReviewInternational urology and nephrology2017
Anticoagulant-related nephropathy: a case report and review of the literature of an increasingly recognized entity.
Review in International urology and nephrology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 35 citations in OpenAlex.
- Percutaneous Nephrostomy and Ureteroscopic Management of Bilateral Renal Papillary Necrosis in an Elderly Female.Cureus · 2025Article
- Acute Kidney Injury in Different Anticoagulation Strategies: A Large-Scale Pharmacoepidemiologic Study Using Real-World Data.Cardiovascular drugs and therapy · 2025Article
- Dabigatran-related Nephropathy Complicated by Tubulointerstitial Nephritis in a Patient with a Normal Renal Function and Undiagnosed IgA Nephropathy.Internal medicine (Tokyo, Japan) · 2024Article
- Lessons for the clinical nephrologist: acute kidney injury during therapy with apixaban.Journal of nephrology · 2024Article
- Pembrolizumab induced-C3 glomerulonephritis and RBC cast nephropathy: a case report.BMC nephrology · 2023Article
- IgA Nephropathy Is the Most Common Underlying Disease in Patients With Anticoagulant-Related Nephropathy.Kidney international reports · 2022Article
- Warfarin-Related Nephropathy Manifested as Diffuse Mesangial Proliferative Glomerulonephritis.Cureus · 2022Article
- Management of Anticoagulant-Related Nephropathy: A Single Center Experience.Journal of clinical medicine · 2021Article
- Systematic DOACs oral anticoagulation in patients with atrial fibrillation and chronic kidney disease: the nephrologist's perspective.Journal of nephrology · 2020Review
- Acute Kidney Injury due to Anticoagulant-Related Nephropathy : A Suggestion for Therapy.Case reports in nephrology · 2020Article
- Dabigatran-induced anticoagulant-related nephropathy with undiagnosed IgA nephropathy in a patient with normal baseline renal function.CEN case reports · 2019Article
- Dabigatran causing severe acute kidney injury in a patient with liver cirrhosis.CEN case reports · 2019Article
- Anticoagulant-Related Nephropathy.Journal of the American Society of Nephrology : JASN · 2018Review
- Dabigatran-Induced Acute Interstitial Nephritis: An Important Complication of Newer Oral Anticoagulation Agents.Journal of clinical medicine research · 2018Article
- Non-bleeding Adverse Events with the Use of Direct Oral Anticoagulants: A Sequence Symmetry Analysis.Drug safety · 2018Article
- Anticoagulant-related nephropathy: a pathological note.Journal of thrombosis and thrombolysis · 2018Article
- Acute kidney injury and undiagnosed immunoglobulin A nephropathy after dabigatran therapy.Proceedings (Baylor University. Medical Center) · 2018Article
- Anticoagulant Related Nephropathy Induced by Dabigatran.Case reports in nephrology · 2018Article
- Anticoagulating atrial fibrillation patients: is there a kidney-friendly choice?Journal of thoracic disease · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Treatment with oral anticoagulants has been associated with worsening kidney function in patients with chronic kidney disease (CKD) as well as among patients without underlying CKD. Thus, anticoagulant-related nephropathy (ARN) is an increasingly recognized entity nowadays, mainly associated with warfarin anticoagulation. Recent evidence indicates that patients treated with the direct anticoagulants may also be at risk of ARN. However, the true incidence of anticoagulant-related nephropathy is difficult to determine. The typical histological lesion involves renal tubular occlusion by red blood cells (RBCs), tubular red blood cell casts on light microscopy and dysmorphic RBCs in the glomerulus on electron microscopy. In the absence of active glomerulonephritis or other inflammatory changes that could account for glomerular hemorrhage, the above findings confirm the diagnosis. Dabigatran etexilate was the first direct oral anticoagulant approved for stroke prevention in patients with non-valvular atrial fibrillation. In this article, we describe a rare case of dabigatran etexilate-induced nephropathy in a patient with preexisting IgA nephropathy and review the recent literature regarding this increasingly recognized entity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.